ERBB2 and breast carcinoma: In a study that examined CD8+ T cell infiltration among 12,439 breast cancer patients, the presence of intratumoral CD8+ T cells was associated with a significant reduction in risk of death in both ER- and ER+, HER2+ breast cancer.